史赛克Stryker Corporation（SYK）2025年第三季度业绩报告「NYSE」（英文版）（9页）.pdf

1、1 1941 Stryker Way Portage,MI 49002 Press release Number:25-24Date:October 30,2025Stryker reports third quarter 2025 operating results Portage,Michigan October 30,2025 Stryker(NYSE:SYK)reported operating results for the third quarter of 2025:Third Quarter Results Reported net sales increased 10.3%to

2、$6.1 billionOrganic net sales increased 9.5%Reported operating income margin of 18.7%Adjusted operating income margin(1)increased 90 bps to 25.6%Reported EPS increased 2.8%to$2.22Adjusted EPS(1)increased 11.1%to$3.19Third Quarter Net Sales Growth OverviewReportedForeign Currency Exchange Constant Cu

3、rrencyAcquisitions/Divestitures OrganicMedSurg and Neurotechnology 14.4%0.5%13.9%5.5%8.4%Orthopaedics 3.9 0.8 3.1(8.3)11.4 Total 10.3%0.7%9.6%0.1%9.5%“We delivered another quarter of strong sales and double-digit adjusted earnings per share growth,”said Kevin A.Lobo,Chair and CEO.“Our teams continue

4、 to execute at a high level,driving performance at the high-end of MedTech and building sustained momentum across our broad portfolio.”Sales Analysis Consolidated net sales of$6.1 billion increased 10.3%in the quarter and 9.6%in constant currency.Organic net sales increased 9.5%in the quarter includ

5、ing 9.1%from increased unit volume and 0.4%from higher prices.MedSurg and Neurotechnology net sales of$3.8 billion increased 14.4%in the quarter and 13.9%in constant currency.Organic net sales increased 8.4%in the quarter including 7.6%from increased unit volume and 0.8%from higher prices.Orthopaedi

6、cs net sales of$2.3 billion increased 3.9%in the quarter and 3.1%in constant currency.Excluding the impact of the divested Spinal implant business,Orthopaedics growth increased 12.5%and 11.7%in constant currency.Organic net sales increased 11.4%in the quarter including 11.7%from increased unit volum